Use of thromboxane A2 antagonists for the manufacture of a medicament for improving post-ischemic myocardial dysfunction

摘要

A method is provided for improving post-ischemic myocardial dysfunction such as contractile dysfunction or reperfusion injury by administering a thromboxane A₂ antagonist before, during or immediately after an ischemic attack.